Header Logo

Connection

CHARLES F LEVENBACK to Bortezomib

Back to Details
This is a "connection" page, showing publications CHARLES F LEVENBACK has written about Bortezomib.
CHARLES F LEVENBACK
Connection Strength
0.016
Bortezomib
  1. Phase I trial of the proteasome inhibitor bortezomib in combination with carboplatin in patients with platinum- and taxane-resistant ovarian cancer. Gynecol Oncol. 2008 Jan; 108(1):68-71.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.